Brought to you by 
LabCorp acquires CRO Covance for $6.1bn
25 Sep 2017
Executive Summary
In a cash and stock deal valued at $6.1bn, medical laboratory testing and services giant Laboratory Corp. of America Holdings (LabCorp) acquired public contract research organization (CRO) Covance Inc. to create a global diagnostics franchise offering partners expanded central lab and patient data analytics as well as complementary lab testing and drug development services.
Deal Industry
- Contract Research, Toxicology Testing-CRO
- In Vitro Diagnostics
- Laboratory Testing Services
- Pharmaceuticals
- Services
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
LabCorp acquires CRO Covance for $6.1bn
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice